These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29267348)

  • 21. Analysis of drug-induced interstitial lung disease caused by herbal medicine using the Japanese Adverse Drug Event Report database.
    Oura K; Tanaka M; Matsumoto K; Satake R; Inoue M; Yoshida Y; Wakabayashi W; Hasegawa S; Iwata M; Suzuki T; Maezawa M; Nakao S; Liao J; Iguchi K; Nakamura M
    BMC Complement Med Ther; 2024 Mar; 24(1):121. PubMed ID: 38486172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Assessment of the Relationship between Hypnotics and Delirium Using the Japanese Adverse Drug Event Report (JADER) Database].
    Kikuchi N; Hazama K; Imai T; Suzuki S; Yoshida Y; Hidaka S
    Yakugaku Zasshi; 2018; 138(7):985-990. PubMed ID: 29962478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Aggression and Antiepileptic Drugs: Analysis Using the Japanese Adverse Drug Event Report (JADER) Database.
    Kawada K; Ishida T; Jobu K; Ohta T; Fukuda H; Morisawa S; Kawazoe T; Tamura N; Miyamura M
    Biol Pharm Bull; 2022; 45(6):720-723. PubMed ID: 35650100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors associated with adverse drug events among older adults in emergency department.
    Chen YC; Fan JS; Chen MH; Hsu TF; Huang HH; Cheng KW; Yen DH; Huang CI; Chen LK; Yang CC
    Eur J Intern Med; 2014 Jan; 25(1):49-55. PubMed ID: 24200546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the Expression Profile of Antibiotic-Induced Thrombocytopenia Using the Japanese Adverse Drug Event Report Database.
    Asai Y; Yamamoto T; Abe Y
    Int J Toxicol; 2021 Dec; 40(6):542-550. PubMed ID: 34658275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the adverse event profiles of conventional and liposomal formulations of doxorubicin using the FDA adverse event reporting system.
    Fukuda A; Tahara K; Hane Y; Matsui T; Sasaoka S; Hatahira H; Motooka Y; Hasegawa S; Naganuma M; Abe J; Nakao S; Takeuchi H; Nakamura M
    PLoS One; 2017; 12(9):e0185654. PubMed ID: 28953936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Categorisation of Pharmaceutical Adverse Events Using the Japanese Adverse Drug Event Report Database: Characteristic Adverse Drug Events of the Elderly Treated with Polypharmacy.
    Negishi A; Oshima S; Horii N; Mutoh M; Inoue N; Numajiri S; Ohshima S; Kobayashi D
    Drugs Real World Outcomes; 2021 Mar; 8(1):49-61. PubMed ID: 33367976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polypharmacy and adverse drug reactions in Japanese elderly taking antihypertensives: a retrospective database study.
    Sato I; Akazawa M
    Drug Healthc Patient Saf; 2013; 5():143-50. PubMed ID: 23843704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of clinical factors associated with Kampo formula-induced pseudoaldosteronism based on self-reported information from the Japanese Adverse Drug Event Report database.
    Uneda K; Kawai Y; Kaneko A; Kayo T; Akiba S; Ishigami T; Yoshida-Komiya H; Suzuki M; Mitsuma T
    PLoS One; 2024; 19(1):e0296450. PubMed ID: 38165850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antidepressant Medication Use and Development of Hyperglycemia and Diabetes Mellitus: A Japanese Adverse Drug Event Report Database Study].
    Mukai J; Maruyama S; Otori K; Kubota R
    Yakugaku Zasshi; 2020; 140(4):591-598. PubMed ID: 32238642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System.
    Raschi E; Poluzzi E; Koci A; Antonazzo IC; Marchesini G; De Ponti F
    Nutr Metab Cardiovasc Dis; 2016 May; 26(5):380-6. PubMed ID: 27067162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of Drug-Induced Liver Injury from Bofutsushosan Administration Using Japanese Adverse Drug Event Report (JADER) Database.
    Ishida T; Kawada K; Jobu K; Kawazoe T; Tamura N; Miyamura M
    Biol Pharm Bull; 2022; 45(4):460-466. PubMed ID: 35370270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of drug-induced hearing loss by using a spontaneous reporting system database.
    Tanaka M; Hasegawa S; Nakao S; Shimada K; Mukai R; Matsumoto K; Nakamura M
    PLoS One; 2019; 14(10):e0217951. PubMed ID: 31593579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database.
    Roberto G; Piccinni C; D'Alessandro R; Poluzzi E
    Cephalalgia; 2014 Jan; 34(1):5-13. PubMed ID: 23921799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Dabigatran- and Warfarin-Associated Hemorrhagic Events Using the FDA-Adverse Event Reporting System Database Stratified by Age.
    Abe J; Umetsu R; Kato Y; Ueda N; Nakayama Y; Suzuki Y; Suzuki T; Nagasawa H; Kinosada Y; Nakamura M
    Int J Med Sci; 2015; 12(4):312-21. PubMed ID: 25897292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statin-associated lower urinary tract symptoms: data mining of the public version of the FDA adverse event reporting system, FAERS.
    Fujimoto M; Hosomi K; Takada M
    Int J Clin Pharmacol Ther; 2014 Apr; 52(4):259-66. PubMed ID: 24472404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004).
    DuMouchel W; Fram D; Yang X; Mahmoud RA; Grogg AL; Engelhart L; Ramaswamy K
    Ann Clin Psychiatry; 2008; 20(1):21-31. PubMed ID: 18297583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polypharmacy of medications and fall-related fractures in older people in Japan: a comparison between driving-prohibited and driving-cautioned medications.
    Iihara N; Bando Y; Ohara M; Yoshida T; Nishio T; Okada T; Kirino Y
    J Clin Pharm Ther; 2016 Jun; 41(3):273-8. PubMed ID: 26990125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-induced hyperglycemia in the Japanese Adverse Drug Event Report database: association of evelolimus use with diabetes.
    Konishi H; Shirakawa J; Arai M; Terauchi Y
    Endocr J; 2019 Jun; 66(6):571-574. PubMed ID: 30944270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems.
    Raschi E; Parisotto M; Forcesi E; La Placa M; Marchesini G; De Ponti F; Poluzzi E
    Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1098-1107. PubMed ID: 29174026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.